BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang ZY, Liu JB, Wang XF, Ma YS, Fu D. Current Status and Prospects of Clinical Treatment of Osteosarcoma. Technol Cancer Res Treat 2022;21:15330338221124696. [PMID: 36128851 DOI: 10.1177/15330338221124696] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Ju Q, Huang R, Hu R, Fan J, Zhang D, Ding J, Li R. Phytic acid-modified manganese dioxide nanoparticles oligomer for magnetic resonance imaging and targeting therapy of osteosarcoma. Drug Deliv 2023;30:2181743. [PMID: 36855959 DOI: 10.1080/10717544.2023.2181743] [Reference Citation Analysis]
2 Yan Q, Yang J, Yao Y, Jia Z, Wang Y, Cheng M, Yan X, Xu Y. Research of the Active Components and Potential Mechanisms of Qingfei Gujin Decoction in the Treatment of Osteosarcoma Based on Network Pharmacology and Molecular Docking Technology. Computational and Mathematical Methods in Medicine 2022;2022:1-12. [DOI: 10.1155/2022/7994425] [Reference Citation Analysis]
3 Hu Z, Wen S, Huo Z, Wang Q, Zhao J, Wang Z, Chen Y, Zhang L, Zhou F, Guo Z, Liu H, Zhou S. Current Status and Prospects of Targeted Therapy for Osteosarcoma. Cells 2022;11:3507. [DOI: 10.3390/cells11213507] [Reference Citation Analysis]